DD150205A5 - Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure - Google Patents

Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure Download PDF

Info

Publication number
DD150205A5
DD150205A5 DD80220683A DD22068380A DD150205A5 DD 150205 A5 DD150205 A5 DD 150205A5 DD 80220683 A DD80220683 A DD 80220683A DD 22068380 A DD22068380 A DD 22068380A DD 150205 A5 DD150205 A5 DD 150205A5
Authority
DD
German Democratic Republic
Prior art keywords
salt
methyl
oxa
acetone
carboxy
Prior art date
Application number
DD80220683A
Other languages
German (de)
English (en)
Inventor
William J Wheeler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD150205A5 publication Critical patent/DD150205A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD80220683A 1979-04-24 1980-04-24 Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure DD150205A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/032,840 US4259485A (en) 1979-04-24 1979-04-24 Crystallization process

Publications (1)

Publication Number Publication Date
DD150205A5 true DD150205A5 (de) 1981-08-19

Family

ID=21867102

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80220683A DD150205A5 (de) 1979-04-24 1980-04-24 Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure

Country Status (34)

Country Link
US (1) US4259485A (bg)
EP (1) EP0018760B1 (bg)
JP (1) JPS55143992A (bg)
KR (1) KR840000036B1 (bg)
AR (1) AR225174A1 (bg)
AT (1) AT368158B (bg)
AU (1) AU531272B2 (bg)
BE (1) BE882849A (bg)
BG (1) BG34904A3 (bg)
CA (1) CA1124236A (bg)
CH (1) CH645901A5 (bg)
CS (1) CS212347B2 (bg)
DD (1) DD150205A5 (bg)
DE (1) DE3067412D1 (bg)
DK (1) DK172880A (bg)
EG (1) EG14334A (bg)
ES (1) ES490828A0 (bg)
FI (1) FI801252A (bg)
FR (1) FR2455043A1 (bg)
GB (1) GB2047703B (bg)
GR (1) GR68048B (bg)
HU (1) HU182127B (bg)
IE (1) IE49703B1 (bg)
IL (1) IL59895A (bg)
IT (1) IT1141294B (bg)
LU (1) LU82384A1 (bg)
NZ (1) NZ193482A (bg)
PH (1) PH15146A (bg)
PL (1) PL124423B1 (bg)
PT (1) PT71115A (bg)
RO (1) RO79315A (bg)
SU (1) SU925251A3 (bg)
YU (1) YU108180A (bg)
ZA (1) ZA802329B (bg)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103185A (en) * 1980-01-22 1981-08-18 Shionogi & Co Ltd Malonamidoxa-dethia-cephem compound
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
RU2555360C2 (ru) * 2012-11-06 2015-07-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ определения воды в координационных соединениях

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1085392A (en) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporins
GB1557552A (en) * 1977-02-15 1979-12-12 Shionogi & Co 1 oxadethiacepham compounds
CA1100962A (en) * 1977-04-28 1981-05-12 Yoshio Hamashima Haloarylmalonamidooxacephalosporins
JPS609718B2 (ja) * 1977-08-25 1985-03-12 塩野義製薬株式会社 チアジアゾリルチオセフアロスポリン類縁抗生物質
BE871213R (fr) * 1978-10-12 1979-02-01 Shionogi & Co Arylmalonamido-1-oxadethiacephalosporines

Also Published As

Publication number Publication date
CA1124236A (en) 1982-05-25
LU82384A1 (fr) 1980-07-31
IT1141294B (it) 1986-10-01
DE3067412D1 (en) 1984-05-17
AU5763380A (en) 1980-10-30
FR2455043B1 (bg) 1983-08-05
EG14334A (en) 1983-12-31
JPS6242915B2 (bg) 1987-09-10
NZ193482A (en) 1982-03-23
GB2047703A (en) 1980-12-03
IE800804L (en) 1980-10-24
PL223649A1 (bg) 1981-02-13
US4259485A (en) 1981-03-31
KR830002778A (ko) 1983-05-30
CS212347B2 (en) 1982-03-26
AR225174A1 (es) 1982-02-26
DK172880A (da) 1980-10-25
ZA802329B (en) 1981-11-25
AU531272B2 (en) 1983-08-18
FR2455043A1 (fr) 1980-11-21
YU108180A (en) 1983-02-28
BG34904A3 (bg) 1983-12-15
EP0018760B1 (en) 1984-04-11
RO79315A (ro) 1982-08-17
HU182127B (en) 1983-12-28
AT368158B (de) 1982-09-27
KR840000036B1 (ko) 1984-01-28
SU925251A3 (ru) 1982-04-30
IT8021527A0 (it) 1980-04-21
ATA207380A (de) 1982-01-15
JPS55143992A (en) 1980-11-10
FI801252A (fi) 1980-10-25
IL59895A (en) 1983-05-15
ES8200110A1 (es) 1981-10-16
GB2047703B (en) 1983-04-20
PT71115A (en) 1980-05-01
BE882849A (fr) 1980-10-20
GR68048B (bg) 1981-10-29
CH645901A5 (fr) 1984-10-31
EP0018760A1 (en) 1980-11-12
IE49703B1 (en) 1985-11-27
PH15146A (en) 1982-08-24
ES490828A0 (es) 1981-10-16
PL124423B1 (en) 1983-01-31

Similar Documents

Publication Publication Date Title
AT399155B (de) Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
CH672788A5 (bg)
WO1993010118A1 (de) Verfahren zur trennung von 5-methyl-tetrahydrofolsäure
EP0112550B1 (de) Kristallisierte Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
DD284807A5 (de) Verf. z. herstellung eine pyhsikalischen gemisches aus mindestens einem salz des ((1-methyl-1-pyrrolidinio)- methyl)-3-cephem-4-carboxylats u. einer pharmazeutisch vertraeglichen, nicht toxischen, organischen oder anorganischen base
EP0078532B1 (de) Kristalline Salze von Cefodizim und Verfahren zu ihrer Herstellung
DE19807972A1 (de) Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
DE2614669C2 (de) Gamma-kristalline wasserfreie Form von 7-(D-alpha-Formyloxy-alpha-phenylacetamido)-3-(1-methyl-1H-tetrazol-5- ylthiomethyl)-3-cephem-4-natriumcarboxylat und Verfahren zu ihrer Herstellung
DD150205A5 (de) Verfahren zur herstellung des d-sesquinatriumsalzes von beta-[d-[carboxy(4-hydroxyphenyl)acetyl]amino]-7 alpha-methoxy-3-[[(1-methyl-1-h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-aza-bicyclo-[4.1.0]oct-2-en-carbonsaeure
DD279483A5 (de) Verfahren zur herstellung von metallkomplexen des n-methyl-11-aza-10-deoxo-10-dihydroerythromycins a und 11-aza-10-deoxo-10-dihydroerythomycins a
DE2066118C3 (de) 14-Desoxy-14-tosyloxyacetoxymutilin und Verfahr en zu dessen Herstellung
DE1143817C2 (de) Verfahren zur Herstellung von 6-Phenoxyacylamidopenicillansaeure-derivaten und von nicht giftigen Salzen derselben
DE3302699C2 (de) N-Methansulfonsäure-Derivate von 3-0-Desmethylistamycin B, Verfahren zu ihrer Herstellung und solche Derivate enthaltende pharmazeutische Mittel
EP0039967B1 (en) Solvate of amoxicillin, process for the preparation thereof and process for the preparation of injectable preparations from this solvate
DE69910810T2 (de) Natriumsalz von 3-(4-cinnamyl-1-piperazinyl)-iminomethyl-rifamycin sv und verfahren zu seiner herstellung
DE1545838C3 (de) 7-(2-Azidooctanamido)-cephalosporansäure, deren Salze und Verfahren zur Herstellung dieser Verbindungen
DD150352A5 (de) Verfahren zur herstellung von antibiotikum 7 beta-[d-[carboxy-(4-hydroxyphenyl)acetyl]-7alpha-methoxy-3-[[(1-methyl-1h-tetrazol-5-yl)thio]methyl]-8-oxo-5-oxa-1-azabicyclo[4.1.0]-oct-2-en-2-carbonsaenrediammoniumsalz
DE3745094B4 (de) Ein kristallines Hydrat der 7ß-[(Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enoylamino]-3-cephem-4-carbonsäure enthaltende Hartgelatinekapsel-Zusammensetzung
DE2549733C2 (de) 1,3-Bis-(β-aethylhexyl)-5-amino-5-methyl-hexahydropyrimidin-terephthalat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
AT393452B (de) Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
AT337366B (de) Verfahren zur herstellung von neuen derivaten des cephalosporins und von ihren salzen
DE69912959T2 (de) Eythromycinderivat mit antibiotischer aktivität
DE2036073A1 (de) Neue Penicilline, ihre Herstellung und Verwendung
AT230539B (de) Verfahren zur Herstellung von neuen Produkten mit antibiotischer Wirkung
AT390440B (de) Verfahren zur herstellung der neuen 7-(3chlor-isoxazol-5-yl)-acetamido-3-(1-methyl1h-1,2,3,4-tetrazol-5-yl)-thiomethyl-ceph3-em-4-carbons|ure